ARCHIVES

Waksal To Pay Back $800,000 In Profits From Stock Sales

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

Komen Foundation Offer Fellowships

February 9, 1996

DCE Advisers Okay Cooperative Agreements For Epidemiolgic Of Esophageal Cancers

March 29, 1991

In Brief: Hatch Bill Would Relax Delaney Clause; Malone Names Acting NIH Head; Search Committee Formed

July 17, 1981